Mereo BioPharma (MREO) Property, Plant & Equipment (Net) (2017 - 2026)

Mereo BioPharma (MREO) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Mereo BioPharma 242.07 Mn 242.07 Mn - 91,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 91,000.00
Mar 31, 2026 91,000.00
Dec 31, 2025 137,000.00
Dec 31, 2025 137,000.00
Sep 30, 2025 174,000.00
Sep 30, 2025 174,000.00
Jun 30, 2025 218,000.00
Jun 30, 2025 218,000.00
Mar 31, 2025 247,000.00
Mar 31, 2025 247,000.00
Dec 31, 2024 257,000.00
Dec 31, 2024 257,000.00
Sep 30, 2024 315,000.00
Sep 30, 2024 315,000.00
Jun 30, 2024 338,000.00
Jun 30, 2024 338,000.00
Mar 31, 2024 360,000.00
Mar 31, 2024 360,000.00
Dec 31, 2023 405,000.00
Dec 31, 2023 405,000.00